Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1972 1
1974 2
1975 1
1976 4
1977 3
1978 3
1980 1
1981 2
1982 5
1983 7
1984 1
1986 2
1987 1
1988 2
1989 2
1990 11
1991 17
1992 21
1993 8
1994 14
1995 4
1996 10
1997 16
1998 4
1999 8
2000 7
2001 7
2002 6
2003 7
2004 8
2005 7
2006 10
2007 9
2008 11
2009 6
2010 11
2011 9
2012 12
2013 4
2014 4
2015 4
2016 1
2017 2
2018 3
2019 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

272 results

Results by year

Filters applied: . Clear all
Page 1
Pertuzumab, trastuzumab, and docetaxel in HER2-positive metastatic breast cancer.
Swain SM, Baselga J, Kim SB, Ro J, Semiglazov V, Campone M, Ciruelos E, Ferrero JM, Schneeweiss A, Heeson S, Clark E, Ross G, Benyunes MC, Cortés J; CLEOPATRA Study Group. Swain SM, et al. N Engl J Med. 2015 Feb 19;372(8):724-34. doi: 10.1056/NEJMoa1413513. N Engl J Med. 2015. PMID: 25693012 Free PMC article. Clinical Trial.
Pertuzumab plus trastuzumab plus docetaxel for metastatic breast cancer.
Baselga J, Cortés J, Kim SB, Im SA, Hegg R, Im YH, Roman L, Pedrini JL, Pienkowski T, Knott A, Clark E, Benyunes MC, Ross G, Swain SM; CLEOPATRA Study Group. Baselga J, et al. N Engl J Med. 2012 Jan 12;366(2):109-19. doi: 10.1056/NEJMoa1113216. Epub 2011 Dec 7. N Engl J Med. 2012. PMID: 22149875 Free PMC article. Clinical Trial.
CHOP-like chemotherapy with or without rituximab in young patients with good-prognosis diffuse large-B-cell lymphoma: 6-year results of an open-label randomised study of the MabThera International Trial (MInT) Group.
Pfreundschuh M, Kuhnt E, Trümper L, Osterborg A, Trneny M, Shepherd L, Gill DS, Walewski J, Pettengell R, Jaeger U, Zinzani PL, Shpilberg O, Kvaloy S, de Nully Brown P, Stahel R, Milpied N, López-Guillermo A, Poeschel V, Grass S, Loeffler M, Murawski N; MabThera International Trial (MInT) Group. Pfreundschuh M, et al. Lancet Oncol. 2011 Oct;12(11):1013-22. doi: 10.1016/S1470-2045(11)70235-2. Epub 2011 Sep 21. Lancet Oncol. 2011. PMID: 21940214 Clinical Trial.
Toremifene in the treatment of breast cancer.
Mustonen MV, Pyrhönen S, Kellokumpu-Lehtinen PL. Mustonen MV, et al. Among authors: pyrhonen s. World J Clin Oncol. 2014 Aug 10;5(3):393-405. doi: 10.5306/wjco.v5.i3.393. World J Clin Oncol. 2014. PMID: 25114854 Free PMC article. Review.
Interferon update.
Pyrhönen S. Pyrhönen S. Urologe A. 2004 Sep;43 Suppl 3:S137-8. doi: 10.1007/s00120-004-0604-8. Urologe A. 2004. PMID: 15148576 No abstract available.
[Paclitaxel, a new anticancer drug].
Jekunen A, Lehtovirta P, Pyrhönen S. Jekunen A, et al. Among authors: pyrhonen s. Duodecim. 1994;110(13):1235-40. Duodecim. 1994. PMID: 7497933 Review. Finnish. No abstract available.
Oral sources of septicaemia in patients with malignancies.
Meurman JH, Pyrhönen S, Teerenhovi L, Lindqvist C. Meurman JH, et al. Among authors: pyrhonen s. Oral Oncol. 1997 Nov;33(6):389-97. doi: 10.1016/s0964-1955(97)00032-8. Oral Oncol. 1997. PMID: 9509121 Review.
272 results